Schistosoma mansoni Enhances Host Susceptibility to Mucosal but Not Intravenous Challenge by R5 Clade C SHIV

• Nagadenahalli B. Siddappa,

  Affiliations Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Girish Hemashettar,

  Affiliation Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Vivekanandan Shanmuganathan,

  Affiliation Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Amma A. Semenya,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Elizabeth D. Sweeney,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Katherine S. Paul,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Sandra J. Lee,

  Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• W. Evan Secor,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Ruth M. Ruprecht

  * E-mail: ruth_ruprecht@dfci.harvard.edu

  Affiliations Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯